Cannabidiol (Artelo Biosciences)

N/A

Report date: 2025/08/04 15:18:33

Base Information

Drug NameCannabidiol (Artelo Biosciences)
Drug Alias NameCBD Cocrystal (Artelo Biosciences)Cannabidiol/tetramethylpyrazine (Artelo Biosciences)ART-12.11ART12.11ART-1211
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsDepressive DisorderAnxietyDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArtelo Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArtelo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDepressive DisorderAnxietyDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A